Share-based Payment Arrangement, Expense of REVELATION BIOSCIENCES, INC. from 31 Mar 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
REVELATION BIOSCIENCES, INC. quarterly and annual Share-based Payment Arrangement, Expense in USD history and change rate from 31 Mar 2021 to 31 Dec 2025.
  • REVELATION BIOSCIENCES, INC. Share-based Payment Arrangement, Expense for the quarter ending 31 Dec 2025 was $370,166, a 410% increase year-over-year.
  • REVELATION BIOSCIENCES, INC. Share-based Payment Arrangement, Expense for the twelve months ending 31 Dec 2025 was $595,368, a 253% increase year-over-year.
  • REVELATION BIOSCIENCES, INC. annual Share-based Payment Arrangement, Expense for 2025 was $595,368, a 253% increase from 2024.
  • REVELATION BIOSCIENCES, INC. annual Share-based Payment Arrangement, Expense for 2024 was $168,850, a 8.4% increase from 2023.
  • REVELATION BIOSCIENCES, INC. annual Share-based Payment Arrangement, Expense for 2023 was $155,721, a 48% decline from 2022.
Source SEC data
View on sec.gov
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

REVELATION BIOSCIENCES, INC. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $595,368 $370,166 +$297,600 +410% 01 Oct 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
Q3 2025 $297,768 $874 -$31,221 -97% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025 2025 Q3
Q2 2025 $328,989 $873 -$31,222 -97% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $360,211 $223,455 +$191,361 +596% 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $168,850 $72,566 +$40,471 +126% 01 Oct 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
Q3 2024 $128,379 $32,095 -$1 -0% 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025 2025 Q3
Q2 2024 $128,380 $32,095 -$27,340 -46% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025 2025 Q2
Q1 2024 $155,720 $32,094 -$1 -0% 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q4 2023 $155,721 $32,095 -$266 -0.82% 01 Oct 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $155,987 $32,096 -$8,579 -21% 01 Jul 2023 30 Sep 2023 10-Q 08 Nov 2024 2024 Q3
Q2 2023 $164,566 $59,435 -$30,753 -34% 01 Apr 2023 30 Jun 2023 10-Q/A 23 Sep 2024 2024 Q2
Q1 2023 $195,319 $32,095 -$105,797 -77% 01 Jan 2023 31 Mar 2023 10-Q/A 23 Sep 2024 2024 Q1
Q4 2022 $301,116 $32,361 -$73,551 -69% 01 Oct 2022 31 Dec 2022 10-K/A 23 Sep 2024 2023 FY
Q3 2022 $374,667 $40,675 -$90,645 -69% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $465,312 $90,188 -$41,133 -31% 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023 2023 Q2
Q1 2022 $506,445 $137,892 +$35,567 +35% 01 Jan 2022 31 Mar 2022 10-Q 22 May 2023 2023 Q1
Q4 2021 $470,878 $105,912 01 Oct 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $131,320 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2022 Q3
Q2 2021 $131,321 01 Apr 2021 30 Jun 2021 10-Q 15 Aug 2022 2022 Q2
Q1 2021 $102,325 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1

REVELATION BIOSCIENCES, INC. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $595,368 +$426,518 +253% 01 Jan 2025 31 Dec 2025 10-K 26 Feb 2026 2025 FY
2024 $168,850 +$13,129 +8.4% 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2023 $155,721 -$145,395 -48% 01 Jan 2023 31 Dec 2023 10-K 06 Mar 2025 2024 FY
2022 $301,116 -$169,762 -36% 01 Jan 2022 31 Dec 2022 10-K/A 23 Sep 2024 2023 FY
2021 $470,878 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.